Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  West Pharmaceutical Services Inc.    WST

WEST PHARMACEUTICAL SERVICES INC. (WST)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales1 4001 5091 5991 7331 8631 975
EBITDA280315337370425473
Operating profit (EBIT)190224240267318355
Pre-Tax Profit (EBT)------
Net income95,6144151207247275
P/E ratio46,344,449,637,131,524,8
EPS ( $ )1,301,911,992,753,234,10
Dividend per Share ( $ )0,460,500,540,570,620,67
Yield0,76%0,59%0,55%0,56%0,60%0,65%
Reference price ( $ )60.2284.8398.67101.88101.88101.88
Announcement Date02/18/2016
12:00pm
02/16/2017
12:17pm
02/15/2018
06:52pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt-25,6----
Finance--38,9296524723
Operating income (EBITDA)280315337370425473
Leverage
(Debt/EBITDA)
-0,08x----
Capital Expenditure132170131141144140
Book Value Per Share (BVPS)14,2 $15,3 $17,3 $19,1 $21,7 $25,1 $
Cash Flow per Share2,88 $2,93 $3,47 $4,18 $4,76 $5,68 $
Announcement Date02/18/2016
12:00pm
02/16/2017
12:17pm
02/15/2018
06:52pm
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 7 483 M$ -
Entreprise Value (EV) 7 186 M$ 6 959 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 37,1x 31,5x
Capitalization / Revenue 4,32x 4,02x
EV / Revenue 4,15x 3,74x
EV / EBITDA 19,4x 16,4x
Yield (DPS / Price) 0,56% 0,60%
Price to book (Price / BVPS) 5,34x 4,70x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 15,4% 17,1%
operating Leverage (Delta EBIT / Delta Sales) 1,35x 2,53x
Net Margin (Net Profit / Revenue) 11,9% 13,3%
ROA (Net Profit / Asset) 10,4% 11,9%
ROE (Net Profit / Equities) 15,2% 16,6%
Rate of Dividend 20,7% 19,0%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   8,14% 7,70%
Cash Flow / Sales 17,7% 18,8%
Capital Intensity (Assets / Sales) 1,15x 1,12x
Financial Leverage (Net Debt / EBITDA) -0,80x -1,23x
EPS & Dividend